Ubiquitin, TAK1 and IKK: Is there a connection?

Cell Death and Differentiation

Volumn 13, Issue 5, 2006, Pages 687-692

  Chen, Zhijian J ^a   Bhoj, V ^a   Seth, R B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROTEASOME; PROTEIN P100; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

APOPTOSIS; B LYMPHOCYTE ACTIVATION; BINDING SITE; CARCINOGENESIS; CELL STIMULATION; CELLULAR IMMUNITY; COMPLEX FORMATION; CYLINDROMA; EDITORIAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE MUTATION; HUMAN; INNATE IMMUNITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; INTERLEUKIN-1; MAP KINASE KINASE KINASES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN;

EID: 33645977821     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401869     Document Type: Editorial

References (57)

1. Baeuerle PA, Baltimore D (1996) Cell 87: 13-20.
2. Chen ZJ et al. (1996) Cell 84: 853-862.
3. Chen ZJ (2005) Nat. Cell Biol. 7: 758-765.
4. Krappmann D, Scheidereit C (2005) EMBO Rep. 6: 321-326.
5. Deng L et al. (2000) Cell 103: 351-361.
6. Wang C et al. (2001) Nature 412: 346-351.
7. Sato S et al. (2005) Nat. Immunol. 6: 1087-1095.
8. Pomerantz JL, Baltimore D (2002) Mol. Cell. 10: 693-695.
9. Hofmann RM, Pickart CM (1999) Cell 96: 645-653.
10. Spence J et al. (1995) Mol. Cell Biol. 15: 1265-1273.
11. Yamaguchi K et al. (1995) Science 270: 2008-2011.
12. Ninomiya-Tsuji J et al. (1999) Nature 398: 252-256.
13. Shibuya H et al. (1996) Science 272: 1179-1182.
14. Takaesu G et al. (2000) Mol. Cell. 5: 649-658.
15. Kanayama A et al. (2004) Mol. Cell. 15: 535-548.
16. Singhirunnusom P et al. (2005) J. Biol. Chem. 280: 7359-7368.
17. Ninomiya-Tsuji J et al. (2003) J. Biol. Chem. 278: 18485-18490.
18. Takaesu G et al. (2003) J. Mol. Biol. 326: 105-115.
19. Ting AT et al. (1996) Embo J. 15: 6189-6196.
20. Kelliher MA et al. (1998) Immunity 8: 297-303.
21. Devin A et al. (2003) EMBO Rep. 4: 623-627.
22. Yeh WC et al. (1997) Immunity 7: 715-725.
23. Lee SY et al. (1997) Immunity 7: 703-713.
24. Tada K et al. (2001) J. Biol. Chem. 276: 36530-36534.
25. Shi CS, Kehrl JH (2003) J. Biol. Chem. 278: 15429-15434.
26. Habelhah H et al. (2004) Embo J. 23: 322-332.
27. Zhang SQ et al. (2000) Immunity 12: 301-311.
28. Legler DF et al. (2003) Immunity 18: 655-664.
29. Lee TH et al. (2004) J. Biol. Chem. 279: 33185-33191.
30. Komatsu Y et al. (2002) Mech. Dev. 119: 239-249.
31. Sanjo H et al. (2003) Mol. Cell Biol. 23: 1231-1238.
32. Ishitani T et al. (2003) Embo J. 22: 6277-6288.
33. Akira S, Takeda K (2004) Nat. Rev. Immunol. 4: 499-511.
34. Irie T et al. (2000) FEBS Lett. 467: 160-164.
35. Silverman N, Maniatis T (2001) Genes Dev. 15: 2321-2342.
36. Vidal S et al. (2001) Genes Dev. 15: 1900-1912.
37. Kaneko T, Silverman N (2005) Cell. Microbiol. 7: 1049-1050.
38. Zhou R et al. (2005) J. Biol. Chem. 280: 34048-34055.
39. Gesellchen V et al. (2005) EMBO Rep. 6: 979-984.
40. Kleino A et al. (2005) EMBO J. 24: 3423-3434.
41. Weil R, Israel A (2004) Curr. Opin. Immunol. 16: 374-381.
42. Zhou H et al. (2004) Nature 427: 167-171.
43. Sun L et al. (2004) Mol. Cell. 14: 289-301.
44. Cannons JL et al. (2002) J. Immunol. 169: 2828-2831.
45. Zhou H et al. (2005) Cancer Cell 7: 425-431.
46. Uren AG et al. (2000) Mol. Cell. 6: 961-967.
47. Shinohara H et al. (2005) J. Exp. Med. 202: 1423-1431.
48. Amerik AY, Hochstrasser M (2004) Biochim. Biophys. Acta. 1695: 189-207.
49. Bignell GR et al. (2000) Nat. Genet. 25: 160-165.
50. Brummelkamp TR et al. (2003) Nature 424: 797-801.
51. Trompouki E et al. (2003) Nature 424: 793-796.
52. Kovalenko A et al. (2003) Nature 424: 801-805.
53. Reiley W et al. (2004) J. Biol. Chem. 279: 55161-55167.
54. Opipari AW et al. (1992) J. Biol. Chem. 267: 12424-12427.
55. Wertz IE et al. (2004) Nature 430: 694-699.
56. Boone DL et al. (2004) Nat. Immunol. 5: 1052-1060.
57. Evans PC et al. (2004) Biochem. J. 378: 727-734.